These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3905004)

  • 1. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of verapamil, gallopamil, diltiazem and nifedipine on sarcoplasmic reticulum function in rat heart.
    Zucchi R; Limbruno U; Ronca-Testoni S; Yu G; Galbani P; Ronca G; Mariani M
    Cardioscience; 1992 Sep; 3(3):167-72. PubMed ID: 1330045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of organic calcium-channel blockers on diastolic SR calcium-handling in the frog heart.
    Subramani S; Vijayanand C; Tharion E
    Br J Pharmacol; 2002 Nov; 137(6):756-60. PubMed ID: 12411405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blocking drugs.
    Johnston WE; Lowenstein E
    Contemp Anesth Pract; 1983; 7():163-91. PubMed ID: 6309475
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium-blockers or calcium antagonists].
    Chávez Rivera I
    Arch Inst Cardiol Mex; 1982; 52(3):259-67. PubMed ID: 7052003
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 10. Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart.
    Tappia PS; Okumura K; Kawabata K; Shah KR; Nijjar MS; Panagia V; Dhalla NS
    Mol Cell Biochem; 2001 May; 221(1-2):89-98. PubMed ID: 11506191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Different sites of action of diltiazem, nifedipine and verapamil on the myocardium and aortic and coronary smooth muscles].
    Raddino R; Poli E; Manca C; Ceconi C; Ferrari R
    Cardiologia; 1986 Jan; 31(1):47-53. PubMed ID: 3742515
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium entry blockers: a review.
    Goad DL
    J Vet Pharmacol Ther; 1982 Dec; 5(4):233-9. PubMed ID: 6306265
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium antagonists.
    Nayler WG
    Eur Heart J; 1980 Jun; 1(3):225-37. PubMed ID: 7285980
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and antiarrhythmic effects of three calcium channel antagonists in ischemic canine hearts.
    Ito T; Ogawa T; Satake T; Hieda N; Sugiyama S; Ozawa T
    Clin Ther; 1989; 11(4):461-71. PubMed ID: 2776164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are calcium antagonists cardioprotective?
    Kendall MJ; Horton RC
    J R Coll Physicians Lond; 1985 Apr; 19(2):85-9. PubMed ID: 3889321
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardioprotective effects of calcium ion antagonists in myocardial ischemia.
    Nayler WG
    Clin Invest Med; 1980; 3(1-2):91-9. PubMed ID: 7471544
    [No Abstract]   [Full Text] [Related]  

  • 18. [The prolonged use of calcium antagonists in myocardial infarct in rats: their effect on hemodynamics and the contractile function and morphology of the heart muscle].
    Kazanova GV; Tsorin IB; Chichkanov GG; Zakharov SP; Shchegolev AI; Iavorskiĭ AN; Liubimov BI
    Eksp Klin Farmakol; 1992; 55(3):17-20. PubMed ID: 1458153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of luliberin on the Ca-accumulating capacity of the myocardial membranes of the rat heart].
    Kravtsov GM; Orlov SN; Pokudin NI
    Biull Eksp Biol Med; 1980 Aug; 90(8):135-7. PubMed ID: 6996760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and mechanisms of action of calcium-channel blockers.
    Katz AM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):28S-37S. PubMed ID: 3540226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.